Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
1997-2-19
|
pubmed:abstractText |
We examined the effect of estrogen replacement therapy (ERT) on plasma serotonin (5HT) and norepinephrine (NE) and their correlation with serum estradiol, luteinizing hormone (LH) and follicle-stimulating hormone (FSH) in 12 postmenopausal women. Plasma 5HT and NE, estrogen, progesterone, LH and FSH were examined every 4 days for 2 consecutive months (before and during ERT). Serotonin values were low (32.29 +/- 38.36 nmol/l) and showed an intrinsic spontaneous cyclicity with a nadir every 10-11 days. Plasma NE was similar to that observed during the follicular phase of the ovulatory cycle (1,216.8 +/- 503.4 pmol/l) and showed no cyclicity. ERT significantly increased mean (+/- SD) serum estrogen values (from 95.40 +/- 73.31 to 390.72 +/- 347.17 pmol/l, P = 0.0001), significantly decreased serum FSH (from 84.04 +/- 14.97 to 52.97 +/- 20.74 mIU/ml, P = 0.0001) and LH (from 35.35 +/- 13.82 mIU/ml to 29.69 +/- 16.46 mIU/ml, P = 0.03). Plasma 5HT levels showed a tendency to rise under the influence of ERT, but this increase was not statistically significant. Plasma NE decreased significantly from 1,216.8 +/- 503.4 to 994.1 +/- 353.89 pmol/l, P <0.05. In conclusion, plasma serotonin in postmenopausal women has a 10-11 day cycle and is significantly lower than in the follicular phase of ovulating women. Plasma NE shows no cyclicity and is significantly decreased by ERT.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Estradiol,
http://linkedlifedata.com/resource/pubmed/chemical/Estrogens, Conjugated (USP),
http://linkedlifedata.com/resource/pubmed/chemical/Follicle Stimulating Hormone,
http://linkedlifedata.com/resource/pubmed/chemical/Luteinizing Hormone,
http://linkedlifedata.com/resource/pubmed/chemical/Medroxyprogesterone Acetate,
http://linkedlifedata.com/resource/pubmed/chemical/Norepinephrine,
http://linkedlifedata.com/resource/pubmed/chemical/Progesterone,
http://linkedlifedata.com/resource/pubmed/chemical/Serotonin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0021-2180
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
32
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1158-62
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:9007144-Aged,
pubmed-meshheading:9007144-Drug Monitoring,
pubmed-meshheading:9007144-Estradiol,
pubmed-meshheading:9007144-Estrogen Replacement Therapy,
pubmed-meshheading:9007144-Estrogens, Conjugated (USP),
pubmed-meshheading:9007144-Female,
pubmed-meshheading:9007144-Follicle Stimulating Hormone,
pubmed-meshheading:9007144-Humans,
pubmed-meshheading:9007144-Luteinizing Hormone,
pubmed-meshheading:9007144-Medroxyprogesterone Acetate,
pubmed-meshheading:9007144-Middle Aged,
pubmed-meshheading:9007144-Norepinephrine,
pubmed-meshheading:9007144-Periodicity,
pubmed-meshheading:9007144-Postmenopause,
pubmed-meshheading:9007144-Progesterone,
pubmed-meshheading:9007144-Serotonin
|
pubmed:year |
1996
|
pubmed:articleTitle |
The effect of estrogen replacement therapy on plasma serotonin and catecholamines of postmenopausal women.
|
pubmed:affiliation |
Institute of Endocrinology, Rabin Medical Center, Petah Tikva, Israel.
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|